ad

Capillary Technologies IPO GMP: Day 1 IPO Live Updates

Posted by : sachet | Fri Nov 14 2025

Capillary Technologies IPO GMP: Day 1 IPO Live Updates

Click & Sign Up to Get Latest Updates on Capillary Technologies IPO

The Capillary Technologies IPO GMP is ₹0 as of 14th November 2025. It is a book-building IPO of ₹877.50 crore, comprising an offer for sale of 0.60 crore shares. The issue will be listed on BSE and NSE on its tentative listing date, 19th November 2025. The face value of Capillary Technologies IPO shares is ₹2 per share, and the IPO price band is set at ₹549 to ₹577 per share. Retail investors can bid for a minimum of 1 lot of 25 shares, worth ₹14,425.

Capillary Technologies IPO Grey Market Premium

As of 14th November 2025, the GMP for the Capillary Technologies IPO stands at ₹85 per share. Thus, the estimated listing price would be ₹482. This indicates that the estimated listing gain in this IPO could be 0.00%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for GMP updates on the Capillary Technologies IPO.

GMP DateIPO PriceGMPEstimated Listing Price Estimated Listing Gains
14-11-2025577.00₹0₹5770.00
13-11-2025577.00₹0₹5770.00
12-11-2025577.00₹0₹5770.00
11-11-2025577.00₹0₹5770.00
10-11-2025577.00₹0₹5770.00
9-11-2025577.00₹0₹5770.00

Capillary Technologies IPO Details

IPO Open Date14th November 2025
IPO Close Date18th November 2025
IPO Allotment Date19th November 2025
Refund Initiation 20th November 2025
Face Value₹2 per share
Price Band₹549 to ₹577 per share
Lot Size25 Shares
Issue Size1,52,07,998 shares(aggregating up to ₹877.50 Cr)
Fresh Issue59,79,202 shares(aggregating up to ₹345.00 Cr)
Offer for sale 92,28,796 shares of ₹2(aggregating up to ₹10.50 Cr)
Issue Type Bookbuilding IPO
Listing AtBSE and NSE
Listing Date21st November 2025

Explanation

Capillary Technologies IPO: Capillary Technologies IPO Limited has announced the issue price of ₹549 to ₹577 per share. With this IPO, the company allows retail investors to bid for one lot of 25 shares worth ₹14,425. The face value of Capillary Technologies IPO Limited shares is ₹2 per share. The shares of Capillary Technologies IPO Limited will be listed on BSE and NSE on its tentative listing day, 21st November 2025. Scroll down to view GMP updates and reviews of the Capillary Technologies IPO. 

Objectives of the Capillary Technologies IPO

The primary objective of the Capillary Technologies IPO is to raise ₹877.50 crore. However, before applying for the IPO, it is essential to be aware of its secondary objectives. 

  • Funding our cloud infrastructure costs
  • Investment in research, designing and development of our products and platform
  • Investment in the purchase of computer systems for our business
  • Funding inorganic growth through unidentified acquisitions and general corporate purposes

Capillary Technologies IPO Registrar

According to recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Capillary Technologies India IPO GMP, allotment, or refund, please contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in  or +91-22-4918 6270.

Capillary Technologies IPO Review  

The Capillary Technologies IPO has gained neutral ratings from industry experts, brokers, and institutional investors. Capillary Technologies Limited’s revenue increased by 14% from ₹535.44 crore in March 2024 to ₹611.87 crore in March 2025. Moreover, the company’s PAT increased by 121% from ₹-68.35 crores to ₹14.15 crores. Investors can analyse other relevant factors and make a decision accordingly. Most analysts recommend applying for this IPO to diversify your investment portfolio. However, we’re waiting for further ratings to gain a better understanding and will continue to post them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Capillary Technologies IPO or not.

Technical Analysis

Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of the Capillary Technologies IPO.

Key IndicatorsValue
PE Ratio (Price-to-Earnings) 298.93
EPS (Earnings Per Share)1.93
RoNW2.85%
ROCE2.76%
ROE[.]
EBITDA Margin13.13%
Price to Book Value8.87
Market Capitalisation₹4,576.09 Cr

The P/E ratio of Capillary Technologies India Limited’s shares is 289.23, and its Earnings Per Share (EPS) is 1.93. Thus, the Capillary Technologies India Limited IPO can deliver gains on its tentative listing day, 21st November 2025.

Note: The data, as mentioned above, is taken from authentic sources and highlights pre-issue information. The PE ratio and EPS of Mittal Solutions Limited are subject to change following the IPO. Refer to the table below for post-issue updates on these two metrics. 

IndicatorsPre-IPOPost-IPO
PE Ratio298.932214.95
EPS 1.930.26

Download the Univest iOS App or the Univest Android App to get daily stock recommendations and insightful research pieces!

FAQs on Capillary Technologies IPO

What is the GMP of the Capillary Technologies IPO?

    As of 13th November 2025, the Capillary Technologies IPO (Grey Market Premium) stands at ₹85. This suggests that the estimated listing price could be 21.41% of the share price.

    What is the issue price of the Capillary Technologies IPO?

      The Capillary Technologies IPO price range is ₹549.00 to ₹577.00 per share. Retail investors can apply for a minimum of 1 lot, each consisting of 25 shares, worth ₹14,425. Moreover, HNIs are required to bid for a minimum of 14 lots (350 shares) worth ₹2,01,950.

      Who is the registrar of the Capillary Technologies IPO?

        According to recent updates, MUFG Intime India Private Limited will be the registrar responsible for managing allotment and refund procedures. For any queries regarding the Capillary Technologies India IPO GMP, allotment, or refund, please contact MUFG Intime India Private Limited at ipo.helpdesk@linkintime.co.in  or +91-22-4918 6270.

        Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Capillary Technologies IPO, download the Capillary Technologies IPO RHP and Capillary Technologies IPO DRHP. Conduct thorough research before investing in IPOs to minimise the risk of significant losses. You can also consult your financial advisor.

        Recent Articles

        Top 10 Penny Stocks in India  | Penny Stocks to Buy in 2025

        Best Stocks to Buy Today: Explore Best Stocks With Expected Trends

        Milky Mist Dairy Foods IPO Details: Everything You Should Know about 

        Karbonsteel Engineering IPO GMP & Review: Should You Apply or Avoid?

        Taurian MPS IPO GMP & Review: Should You Apply or Avoid?

        Shringar House of Mangalsutra IPO GMP & Review: Apply or Avoid?

        Dev Accelerator IPO GMP & Review: Apply or Avoid?

        Krupalu Metals IPO GMP: Day 3 IPO Live Updates

        icon

        100% Safe & Secure Platform.

        Univest encrypts all data and transactions to ensure a completely secure experience for our members.

        Copyright

        2025 Univest. All rights reserved. | Designed with ❤️ in India
        About Univest
        About: Univest is a cutting-edge stock market platform designed to help traders and investors maximize their returns with expert-driven advisory services and seamless trading execution. Whether you're a seasoned trader or just starting, Univest simplifies your investment journey with actionable trade recommendations, AI-powered portfolio insights, and a fully integrated brokerage experience. With Univest, you gain access to proven stock market advisory, offering expert trade ideas for stocks, futures, options, and commodities. Our one-click trade execution feature eliminates slippage, ensuring instant execution through our advisory-first brokerage. Smart portfolio management allows you to identify underperforming stocks, optimize your investments, and receive real-time alerts. Additionally, Univest provides seamless investment opportunities beyond stocks, including mutual funds, bonds, fixed deposits, and insurance (coming soon). Join over 40 lakh active investors who trust Univest to make informed and profitable trading decisions. Start investing smarter today! 🚀  
        Attention Investors : To ensure a smooth trading experience and prevent unauthorized transactions, investors must update their mobile number and email ID with their stockbroker or depository participant. As per regulatory requirements, investors are required to pay a stipulated amount as an upfront margin for trading in the Cash/FO segment. We encourage all investors to regularly check their securities in the Consolidated Account Statement (CAS) issued by depository to verify their holdings.Always verify alerts and transaction details received directly from the exchange or NSDL before proceeding with any trades. Please do not make payments through unverified email links, WhatsApp, or SMS. Always trade through a registered stockbroker and verify all details before making financial decisions.
         
        Disclaimer: Investments in the securities market are subject to market risks. Please read all related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. For more disclaimer /disclosure, visit https://univest.in/stock-broker or Univest App.We collect and use your contact information for legitimate business purposes, including providing updates on our products and services. We do not sell or rent your contact information to third parties. By submitting your details, you authorize us to contact you via Call/SMS, even if you are registered under DND. This authorization remains valid for 12 months.For grievances, please contact us at hello@unibrokers.in .
         
        Univest Stock Broking Disclosures
        Univest Stock Broking Private Limited - SEBI Reg. No. INZ000317437 (Stock Broker), NSE TM Code: 90392, BSE TM Code: 6866, MCX TM Code: 57290 and ICCL- Self Clearing Member Code: 6866, SEBI Reg. No. IN-DP-779-2024 (Participant), NSDL DP ID: IN304748.
         Risk Disclosures on Derivatives
        1. 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
        2. On an average, loss makers registered net trading loss close to ₹ 50,000
        3. Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
        4. Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
        Attention Investors: As per NSE circular dated July 6, 2022: https://nsearchives.nseindia.com/content/circulars/INSP52900.pdf, BSE circular dated July 6, 2022: https://www.bseindia.com/markets/MarketInfo/DispNewNoticesCirculars.aspx?page=20220706-55, MCX circular dated July 11, 2022: https://www.mcxindia.com/docs/default-source/circulars/english/2022/july/circular-418-2022.pdf?sfvrsn=9401991_0, investors are cautioned to abstain them from dealing in any schemes of unauthorised collective investments/portfolio management, indicative/ guaranteed/fixed returns / payments etc. 
        Investors are further cautioned to avoid practices like:
        a. Sharing 
        i) trading credentials – login id and passwords including OTPs.
        ii) trading strategies,
        iii) position details.
        b. Trading in leveraged products /derivatives like Options without proper understanding, which could lead to losses.
        c. Writing/ selling options or trading in option strategies based on tips, without basic knowledge and understanding of the product and its risks.
        d. Dealing in unsolicited tips through platforms like Whatsapp, Telegram, Instagram, YouTube, Facebook, SMS, calls, etc.
        e. Trading / Trading in “Options” based on recommendations from unauthorised / unregistered investment advisors and influencers.
         Kindly read the Advisory Guidelines For Investors as prescribed by the Exchange with reference to their circular dated 27th August, 2021 regarding investor awareness and safeguarding client’s assets: https://nsearchives.nseindia.com/content/circulars/INSP49434.pdf
        Kindly, read the advisory as prescribed by the Exchange with reference to their circular: NSE/ISC/51035 dated January 14, 2022 regarding Updation of mandatory KYC fields by March 31, 2022: https://www.nseindia.com/resources/exchange-communication-circulars# 
        Attention Investors: Prevent unauthorised transactions in your Demat account by updating your mobile number with your depository participant. Receive alerts on your registered mobile number for debit and other important transactions in your Demat account directly from NSDL on the same day. Prevent unauthorised transactions in your Trading account by updating your mobile numbers/email addresses with your stock brokers. Receive information on your transactions directly from the Exchange on your mobile/email at the end of the day. Issued in the interest of investors. KYC is a one-time exercise while dealing in securities markets - once KYC is done through a SEBI-registered intermediary (Broker, DP), you need not undergo the same process again when you approach another intermediary. As a business, we don’t give stock tips and have not authorised anyone to trade on behalf of others. If you find anyone claiming to be part of Univest Stock Broking Private Limited and offering such services, please send us an email at hello@unibrokers.in
        No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account.
        Update your email ID and mobile number with your stockbroker/depository participant and receive an OTP directly from the depository on your registered email ID and/or mobile number. Check your securities/mutual funds/bonds in the Consolidated Account Statement (CAS) issued by NSDL every month.
        Attention Investors: SEBI has established an Online Dispute Resolution Portal (ODR Portal) for resolving disputes in the Indian Securities Market. This circular streamlines the existing dispute resolution mechanism, offering online conciliation and arbitration, benefiting investors and listed companies https://www.sebi.gov.in/legal/circulars/jul-2023/online-resolution-of-disputes-in-the- indian-securities-market_74794.html. ODR portal for Investors - https://smartodr.in/login.
        Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
        General
        arrow down